Brief: Roche Q3 Sales Up 7% At Constant Exchange Rates
Thu 06:12
BRIEF-Roche Q3 Sales Up 7% At Constant Exchange Rates Oct 22 (Reuters) - ROCHE HOLDING AG ROPC.S:
THIRD QUARTER SALES GROWTH OF +7% AT CONSTANT EXCHANGE RATES (CER) AND +8% IN CHF
9-MONTH GROUP SALES WERE +6% AT CONSTANT EXCHANGE RATES (CER)(1), +1% WHEN REPORTED IN CHF AND +7% IN USD(2)
9-MONTH PHARMACEUTICALS DIVISION SALES WERE +7% AT CER, +2% WHEN REPORTED IN CHF AND +8% IN USD
9-MONTH DIAGNOSTICS DIVISION SALES WERE +4% AT CER, STABLE WHEN REPORTED IN CHF AND +6% IN USD
OUTLOOK FOR 2026 CONFIRMED
Source text: ID:nGNE66h48K
Further company coverage: ROPC.S
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Roche Holding AG
See all newsNovartis presents weaker-than-expected relapse data for multiple sclerosis drug remibrutinib
Brief: Roche Says Sefaxersen Achieved Statistically Significant 43.1% Reduction In Proteinuria In Interim Phase III Data
Brief: Zymeworks Signs Exclusive Global Licensing Deal With Roche For Cancer Drug ZW209
Zymeworks licenses experimental lung cancer drug to Roche in up to $813 million deal
DB ups Roche to 'buy' on positive oncology survey